{
    "filename": "pdf.pdf",
    "content_type": "application/pdf",
    "file_size": 97232,
    "metadata": {
        "identifiers": {
            "doi": "10.1016/s0140-6736(20)30419-0",
            "arxiv": null,
            "isbn": null,
            "doc_id": null,
            "url": "http://www.thelancet.com/article/S0140673620304190/pdf"
        },
        "title": "A distinct name is needed for the new coronavirus",
        "author": "Shibo Jiang, Zhengli Shi, Yuelong Shu, Jingdong Song, George F Gao, Wenjie Tan, Deyin Guo",
        "date": 2020,
        "affiliations": [
            "National Institute for Viral Disease Control and Prevention, China CDC"
        ],
        "journal": "The Lancet",
        "links": [
            "https://www.usatoday.com/",
            "http://www.thelancet.com",
            "https://www.\ninfluenza.6",
            "https://doi.org/10.1016/",
            "http://ees.elsevier.com/"
        ],
        "emails": [
            "guodeyin@mail.sysu.edu.cn"
        ],
        "cited_by": 4,
        "references": "",
        "references_ris": "",
        "author_conclusions": [],
        "table_captions": [],
        "figure_captions": []
    },
    "sections": {
        "introduction": [
            "An outbreak of unusual respiratory name SARS-CoV-2 might have 5 Gorbalenya AE, Baker SC, Baric RS, et al.",
            "disease, initially dominated by adverse effects on the social stability pneumonia, in Wuhan, China, is caused and economic development in"
        ]
    },
    "structured_content": {},
    "participants": [],
    "statistics": [],
    "keywords": [
        "baker sc",
        "social stability pneumonia",
        "Coronavirus Study Group",
        "Viral disease",
        "gorbalenya ae",
        "new coronavirus",
        "SARS",
        "baric rs",
        "unusual respiratory name sars cov",
        "economic development",
        "adverse effect"
    ],
    "keyword_relevance": {
        "SARS": 0.6296296296296297,
        "Coronavirus Study Group": 0.14814814814814814,
        "new coronavirus": 0.1111111111111111,
        "social stability pneumonia": 0.037037037037037035,
        "economic development": 0.037037037037037035,
        "adverse effect": 0.037037037037037035,
        "baker sc": 0.0,
        "Viral disease": 0.0,
        "gorbalenya ae": 0.0,
        "baric rs": 0.0,
        "unusual respiratory name sars cov": 0.0
    },
    "species": [],
    "summary": [
        "An outbreak of unusual respiratory name SARS-CoV-2 might have 5 Gorbalenya AE, Baker SC, Baric RS, et al.",
        "A distinct name is could evolve to a low pathogenic 3 Wu F, Zhao S, Yu B, et al A new coronavirus needed for the new coronavirus but highly transmissible coronavirus, which might return every winter, associated with human respiratory disease in China.",
        "Nature 2020; published online Feb 3.",
        "Disease, initially dominated by adverse effects on the social stability pneumonia, in Wuhan, China, is caused and economic development in",
        "Countries where the virus is causing The new virus was initially named an epidemic, perhaps even around bioRxiv 2020; published online Feb 11.",
        "On Feb 11, 2020, WHO renamed the thought of a re-occurrence of the disease as coronavirus disease SARS.",
        "Https://www.usatoday.com/ story/news/health/2020/02/06/coronaviruswuhan-china-recurring-winter-illnessflu/4665482002/.",
        "Published Online February 18, 2020 https://doi.org/10.1016/ S0140-6736(20)30419-0 the Coronavirus Study Group (CSG) ongoing epidemic or even sporadic of the International Committee on cases of SARS.",
        "Virus Taxonomy posted a manu\u00ad that, like SARS-CoV, 2019-nCoV will script on bioRxiv in which they not re-emerge once the current outsuggested designating 2019-nCoV break ends; they might not as severe acute respiratory syndrome be prepared to prevent 2019-nCoV",
        "Coronavirus 2 (SARS-CoV-2) on the infection in the near future and could basis of a phylogenetic analysis of lose a sense of alert.",
        "Related coronaviruses.5 The CSG claimed On the basis of special clinical, that they did not intend to make any virolog\u00adical, and epidemiological reference to SARS when introducing characteristics and the uncertainty yet another virus name derived from of the novel coronavirus, to avoid the term SARS; SARS is a the misleadingness and confusion, disease name, and to name new virus and to help scientists and the public",
        "SARS-CoV-2 implies that it with better communication, we, a causes SARS or similar, especially to group of virologists in China, suggest scientists without much knowledge renaming SARS-CoV-2 as human of virology and to citizens in the public coronavirus 2019 (HCoV-19).",
        "The new name is not a name distinguishes the virus from consistent with the disease name SARS-CoV and keeps it consistent with",
        "SARS-CoV-2, as a naturally the WHO name of the disease it causes, occurring virus, is different from COVID-19.",
        "As of Feb 17, 2020, 2019-nCoV has caused 71 331 human infections and 1775 deaths in China and 24 other countries, and it is distinct from SARS-CoV in biological, epide\u00ad",
        "Www.thelancet.com Published online February 18, 2020 https://doi.org/10.1016/S0140-6736(20)30419-0"
    ],
    "structured_summary": {
        "Introduction": [
            "An outbreak of unusual respiratory name SARS-CoV-2 might have 5 Gorbalenya AE, Baker SC, Baric RS, et al.",
            "A distinct name is could evolve to a low pathogenic 3 Wu F, Zhao S, Yu B, et al A new coronavirus needed for the new coronavirus but highly transmissible coronavirus, which might return every winter, associated with human respiratory disease in China.",
            "Nature 2020; published online Feb 3."
        ],
        "Results": [
            "Disease, initially dominated by adverse effects on the social stability pneumonia, in Wuhan, China, is caused and economic development in",
            "Countries where the virus is causing The new virus was initially named an epidemic, perhaps even around bioRxiv 2020; published online Feb 11.",
            "On Feb 11, 2020, WHO renamed the thought of a re-occurrence of the disease as coronavirus disease SARS.",
            "Https://www.usatoday.com/ story/news/health/2020/02/06/coronaviruswuhan-china-recurring-winter-illnessflu/4665482002/.",
            "Published Online February 18, 2020 https://doi.org/10.1016/ S0140-6736(20)30419-0 the Coronavirus Study Group (CSG) ongoing epidemic or even sporadic of the International Committee on cases of SARS.",
            "Virus Taxonomy posted a manu\u00ad that, like SARS-CoV, 2019-nCoV will script on bioRxiv in which they not re-emerge once the current outsuggested designating 2019-nCoV break ends; they might not as severe acute respiratory syndrome be prepared to prevent 2019-nCoV",
            "Coronavirus 2 (SARS-CoV-2) on the infection in the near future and could basis of a phylogenetic analysis of lose a sense of alert.",
            "Related coronaviruses.5 The CSG claimed On the basis of special clinical, that they did not intend to make any virolog\u00adical, and epidemiological reference to SARS when introducing characteristics and the uncertainty yet another virus name derived from of the novel coronavirus, to avoid the term SARS; SARS is a the misleadingness and confusion, disease name, and to name new virus and to help scientists and the public",
            "SARS-CoV-2 implies that it with better communication, we, a causes SARS or similar, especially to group of virologists in China, suggest scientists without much knowledge renaming SARS-CoV-2 as human of virology and to citizens in the public coronavirus 2019 (HCoV-19).",
            "The new name is not a name distinguishes the virus from consistent with the disease name SARS-CoV and keeps it consistent with"
        ],
        "Conclusion": [
            "SARS-CoV-2, as a naturally the WHO name of the disease it causes, occurring virus, is different from COVID-19.",
            "As of Feb 17, 2020, 2019-nCoV has caused 71 331 human infections and 1775 deaths in China and 24 other countries, and it is distinct from SARS-CoV in biological, epide\u00ad",
            "Www.thelancet.com Published online February 18, 2020 https://doi.org/10.1016/S0140-6736(20)30419-0"
        ]
    },
    "reference_links": [],
    "facts": [
        "et al A new coronavirus needed for the new coronavirus",
        "WHO renamed the thought of a re-occurrence of the disease",
        "Related coronaviruses.5 The CSG claimed On the basis of special clinical"
    ],
    "claims": [],
    "findings": [],
    "processes": [],
    "key_statements": [
        "A distinct name is could evolve to a low pathogenic 3 Wu F, Zhao S, Yu B, et al A new coronavirus needed for the new coronavirus but highly transmissible coronavirus, which might return every winter, associated with human respiratory disease in China",
        "On Feb 11, 2020, WHO renamed the thought of a re-occurrence of the disease as coronavirus disease SARS"
    ],
    "top_statements": [
        "An outbreak of unusual respiratory name SARS-CoV-2 might have 5 Gorbalenya AE, Baker SC, Baric RS, et al",
        "A distinct name is could evolve to a low pathogenic 3 Wu F, Zhao S, Yu B, et al A new coronavirus needed for the new coronavirus but highly transmissible coronavirus, which might return every winter, associated with human respiratory disease in China",
        "On Feb 11, 2020, WHO renamed the thought of a re-occurrence of the disease as coronavirus disease SARS"
    ],
    "headline": "A distinct name is could evolve to a low pathogenic 3 Wu F, Zhao S, Yu B, et al A new coronavirus needed for the new coronavirus but highly transmissible coronavirus, which might return every winter, associated with human respiratory disease in China",
    "contexts": [],
    "abbreviations": {
        "CSG": "Coronavirus Study Group"
    }
}
